Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/THIOGENESIS THERAPEUTICS CORP/ D

SEC Filing · D

THIOGENESIS THERAPEUTICS CORP

TTIPFOTCEQUITYCurrent

SEC Filing

Filed Dec 20, 2023Accepted Dec 20, 2023, 10:18 AM ESTCIK 1877778Accession 0001062993-23-022931
View company →Permanent SEC source ↗
Share

Company context

Current securities

TTIPFOTC · EQUITY · Current

Recent company filings

  1. D filingJun 9, 2026
  2. D filingAug 8, 2025
  3. D filingNov 25, 2022
  4. D filingAug 11, 2021

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗